Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TIPIRACIL\TRIFLURIDINE Cause Product communication issue? 17 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Product communication issue have been filed in association with TIPIRACIL\TRIFLURIDINE. This represents 0.2% of all adverse event reports for TIPIRACIL\TRIFLURIDINE.

17
Reports of Product communication issue with TIPIRACIL\TRIFLURIDINE
0.2%
of all TIPIRACIL\TRIFLURIDINE reports
4
Deaths
7
Hospitalizations

How Dangerous Is Product communication issue From TIPIRACIL\TRIFLURIDINE?

Of the 17 reports, 4 (23.5%) resulted in death, 7 (41.2%) required hospitalization.

Is Product communication issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TIPIRACIL\TRIFLURIDINE. However, 17 reports have been filed with the FAERS database.

What Other Side Effects Does TIPIRACIL\TRIFLURIDINE Cause?

Death (3,017) Disease progression (1,774) Fatigue (1,298) Nausea (1,135) Diarrhoea (965) Decreased appetite (659) Vomiting (628) White blood cell count decreased (483) Asthenia (472) Anaemia (388)

What Other Drugs Cause Product communication issue?

EVOLOCUMAB (2,341) SEMAGLUTIDE (842) ERENUMAB-AOOE (598) SOMATROPIN (350) PEGFILGRASTIM (333) ETANERCEPT (122) ALBUTEROL (121) NIRMATRELVIR\RITONAVIR (70) DENOSUMAB (68) LEVODOPA (61)

Which TIPIRACIL\TRIFLURIDINE Alternatives Have Lower Product communication issue Risk?

TIPIRACIL\TRIFLURIDINE vs TIPRANAVIR TIPIRACIL\TRIFLURIDINE vs TIRAGOLUMAB TIPIRACIL\TRIFLURIDINE vs TIRBANIBULIN TIPIRACIL\TRIFLURIDINE vs TIROFIBAN TIPIRACIL\TRIFLURIDINE vs TIRZEPATIDE

Related Pages

TIPIRACIL\TRIFLURIDINE Full Profile All Product communication issue Reports All Drugs Causing Product communication issue TIPIRACIL\TRIFLURIDINE Demographics